Skip to main content
. 2023 Jan 9;14:1058665. doi: 10.3389/fnagi.2022.1058665

Figure 1.

Figure 1

ELISA analysis of growth differentiation factor 15 (GDF15) levels in cerebrospinal fluid (CSF) and plasma. (A) GDF15 CSF level in 8 non-AD subjects (non-AD), 20 AD patients with low T-Tau CSF level [Alzheimer’s disease (AD) low T-Tau], and 20 AD patients with a high CSF T-Tau level (AD high T-Tau). (B) Regression analysis of GDF15 levels in CSF and plasma of the same subjects.